Yield10 Bioscience Inc (YTEN)

[RandolRocketman]

Metabolix's Q4 Loss Narrower Than Expected, Beats on Revenue
BY Midnight Trader
— 4:54 PM ET 03/19/2015
04:54 PM EDT, 03/19/2015 (MT Newswires) -- Metabolix (MBLX) is higher in the after hours session after the company said that for Q4, its loss was narrower than expected and revenue topped analysts' forecasts.
Shares are up 3.8% at $0.83 with a 52-week range of $0.25 - $1.63.
The biomaterials company focused on sustainable solutions for the plastics industry reported Q4 net loss from continuing operations of $5.8 million, or $0.05 loss per share, compared with the prior-year period's $8.0 million, or $0.23 loss per share. The single analyst estimate on Capital IQ is for a $0.12 loss per share.
Revenue was $0.9 million, up from $0.7 million in the same quarter last year. The average estimate from two analysts is for revenue of $0.6 million.
Price: 0.83, Change: +0.03, Percent Change: +3.75
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.